Literature DB >> 4897003

Experimental studies related to autoimmunity in myasthenia gravis.

B M Kaufman, G Rushworth, R Wright.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4897003      PMCID： PMC496514          DOI： 10.1136/jnnp.32.4.281

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  40 in total

1.  MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS.

Authors:  H VAN DER GELD; T E FELTKAMP; J VAN LOGHEM; H J OOSTERHUIS; A BIEMOND
Journal:  Lancet       Date:  1963-08-24       Impact factor: 79.321

2.  PATHOGENESIS OF THE HYPERTHYROIDISM OF GRAVES'S DISEASE.

Authors:  D D ADAMS
Journal:  Br Med J       Date:  1965-04-17

3.  Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis.

Authors:  W L NASTUK; A J STRAUSS; K E OSSERMAN
Journal:  Am J Med       Date:  1959-03       Impact factor: 4.965

4.  Does myasthenic serum bind to the neuromuscular junction?

Authors:  D E McFarlin; W K Engel; A J Strauss
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

5.  Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications.

Authors:  A J Strauss; C W Smith; G W Cage; H W van der Geld; D E McFarlin; M Barlow
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

6.  Muscle antibodies in myasthenic mothers and their babies.

Authors:  H J Oosterhuis; T E Feltkamp; H R van der Geld
Journal:  Lancet       Date:  1966-12-03       Impact factor: 79.321

7.  Autoimmunity in myasthenia gravis: a family study.

Authors:  R Wright; J H Kerr
Journal:  Clin Exp Immunol       Date:  1967-01       Impact factor: 4.330

8.  Autoantibodies and myasthenia gravis, with special reference to muscle ribonucleoprotein.

Authors:  T Namba; D Grob
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

9.  Presynaptic mechanisms in myasthenia gravis.

Authors:  J E Desmedt
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

10.  Myasthenia gravis. Immunological relationship between striated muscle and thymus.

Authors:  H W van der Geld; A J Strauss
Journal:  Lancet       Date:  1966-01-08       Impact factor: 79.321
View more
  8 in total

1.  Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis.

Authors:  W M Behan; P O Behan; J A Simpson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-11       Impact factor: 10.154

2.  Experimental myasthenia gravis, myositis and myocarditis in guinea-pigs immunized with subcellular fractions of calf thymus or calf skeletal muscle in Freund's complete adjuvant.

Authors:  J R Kalden; W G Williamson; W J Irvine
Journal:  Clin Exp Immunol       Date:  1973-01       Impact factor: 4.330

3.  The effect of thymectomy, hemi-thymectomy and sham thymectomy on experimental myasthenia gravis in guinea-pigs.

Authors:  J R Kalden; W G Williamson; W J Irvine
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

4.  [On the impaired neuromuscular transmission in myasthenia gravis].

Authors:  P Kruckenberg; W Pontzen; R Sandweg; H Bauer
Journal:  Z Neurol       Date:  1971

5.  Experimental myasthenia in mice. The role of the thymus and lymphoid cells.

Authors:  S Kawanami; R Mori
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

6.  The thymus in autoimmune disease.

Authors:  W J Irvine
Journal:  Proc R Soc Med       Date:  1970-07

Review 7.  Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia.

Authors:  R L Dawkins
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

8.  An investigation of experimental myasthenia gravis.

Authors:  S F Jones; J L Brennan; J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-08       Impact factor: 10.154
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.